$2.365
-0.054 (-2.27%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
APVO Prediction & Forecast by Similar Chart Analysis
Alphio's APVO stock price prediction model matches the current Aptevo Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.35 (-0.55%). The 1-week path is $2.43 (+2.93%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Aptevo Therapeutics Inc Stock?
Aptevo Therapeutics is not a good buy right now due to its significantly negative financial performance and poor technical indicators. The current price is $2.37, and the RSI is extremely low at 16.495, indicating oversold conditions. Additionally, the company has a forward P/E of 3.8895, which suggests it is undervalued, but the recent 5-day change of -11.75% and 20-day change of -42.46% indicate a strong downward trend. The main risk is the company's continued negative earnings, with a GAAP EPS of -$87.27 reported, which raises concerns about its financial viability.
APVO stock price ended at $2.37 on Friday, after losing -2.27%
Aptevo Therapeutics Inc (APVO) last closed at $2.365, losing -2.27%. These facts feed the 1-day and 1-week APVO price prediction above.
Analyst Consensus
Aptevo Therapeutics Inc (APVO): 1 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Aptevo Therapeutics Inc (APVO) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches APVO, ranked by similarity.
Seasonality analysis for APVO
Historically the probability of a positive August return for APVO is 0.00%. January offers the highest probability of a positive month at 16.39%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for APVO
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.10 | $3.43 | $3.59 | +45.10% |
| Sep 2026 | $2.89 | $3.03 | $3.58 | +28.01% |
| Oct 2026 | $2.27 | $2.72 | $3.11 | +15.15% |
| Nov 2026 | $2.45 | $2.90 | $2.93 | +22.63% |
| Dec 2026 | $2.54 | $2.81 | $3.29 | +18.78% |
In 2026, Aptevo Therapeutics Inc (APVO) is projected to range from $2.27 to $3.59.
Aptevo Therapeutics Inc 2026 monthly forecast
In Aug 2026, Aptevo Therapeutics Inc is projected to average $3.43, with a low of $3.10 and high of $3.59.
In Sep 2026, Aptevo Therapeutics Inc is projected to average $3.03, with a low of $2.89 and high of $3.58.
In Oct 2026, Aptevo Therapeutics Inc is projected to average $2.72, with a low of $2.27 and high of $3.11.
In Nov 2026, Aptevo Therapeutics Inc is projected to average $2.90, with a low of $2.45 and high of $2.93.
In Dec 2026, Aptevo Therapeutics Inc is projected to average $2.81, with a low of $2.54 and high of $3.29.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.